| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Aug 22, 2019 | ELAN Elanco Animal Health Inc | Hoover R David50 | Director | Buy | 15,000 | $26.96 | $404,400.00 | +1,630% | |
| Aug 22, 2019 | BTAI Bioxcel Therapeutics, Inc. | Mueller Peter | Director | Buy | 8,446 | $8.74 | $73,840.18 | +2.7% | |
| Aug 21, 2019 | SCYX Scynexis Inc | Taglietti Marco | Chief Executive Officer | Buy | 10,000 | $1.11 | $11,100.00 | +1.0% | |
| Aug 21, 2019 | AQST Aquestive Therapeutics, Inc. | Scibetta James S | Director | Buy | 22,971 | $3.79 | $86,977.07 | +39.1% | |
| Aug 21, 2019 | CPIX Cumberland Pharmaceuticals Inc | Bernard Gordon R | Director | Sell | 6,309 | $5.46 | $34,432.21 | -3.1% | |
| Aug 20, 2019 | ANIK Anika Therapeutics, Inc. | Bower Joseph L. | Director | Sell | 1,994 | $55.57 | $110,806.58 | -4.4% | |
| Aug 20, 2019 | TXMD Therapeuticsmd, Inc. | Finizio Robert G | CEO | Buy | 35,000 | $2.74 | $95,900.00 | +0.2% | |
| Aug 20, 2019 | ANIP Ani Pharmaceuticals Inc | Meridian Venture Partners II LP | 10% Owner | Sell | 7,579 | $68.21 | $516,984.26 | -0.2% | |
| Aug 19, 2019 | BHC Bausch Health Companies Inc. | McKenna Mark C. | President, Salix | Sell | 10,773 | $21.83 | $235,220.91 | -34.2% | |
| Aug 19, 2019 | ZTS Zoetis Inc. | Lagano Roxanne70 | Executive Vice President | Sell | 4,463 | $125.99 | $562,293.37 | -13.4% | |
| Aug 16, 2019 | BHC Bausch Health Companies Inc. | Humphries William D. | President, Ortho-dermatologics | Buy | 30,703 | $21.18 | $650,142.17 | +26.2% | |
| Aug 16, 2019 | IRWD Ironwood Pharmaceuticals Inc | Consylman Gina | SVP, CFO &Treasurer | Sell | 212 | $9.04 | $1,916.48 | -0.1% | |
| Aug 16, 2019 | TXMD Therapeuticsmd, Inc. | Milligan John C.K. IV | President/ Secretary | Buy | 10,000 | $2.93 | $29,300.00 | +0.3% | |
| Aug 16, 2019 | AMRX Amneal Pharmaceuticals, Inc. | Bhadauria Pradeep | SVP, Chief Scientific Officer | Buy | 30,000 | $2.41 | $72,300.00 | +400.0% | |
| Aug 16, 2019 | BTAI Bioxcel Therapeutics, Inc. | Mehta Vimal92 | CEO, President And Secretary | Buy | 974 | $8.89 | $8,658.86 | +10.8% | |
| Aug 16, 2019 | ANIP Ani Pharmaceuticals Inc | Meridian Venture Partners II LP | 10% Owner | Sell | 62,024 | $69.04 | $4,282,305.91 | -0.9% | |
| Aug 15, 2019 | SCYX Scynexis Inc | Taglietti Marco | Chief Executive Officer | Buy | 10,015 | $1.01 | $10,115.15 | +2.0% | |
| Aug 15, 2019 | PCRX Pacira Biosciences, Inc. | Stack David M67 | CEO And Chairman | Sell | 12,849 | $39.15 | $503,092.41 | -3.9% | |
| Aug 15, 2019 | AMPH Amphastar Pharmaceuticals, Inc. | Peters William J52 | CFO, SVP &Treasurer | Sell | 4,942 | $21.00 | $103,782.00 | -5.7% | |
| Aug 15, 2019 | TXMD Therapeuticsmd, Inc. | Russell Angus C. | Director | Buy | 35,000 | $2.83 | $98,900.00 | +28.7% | |
| Aug 15, 2019 | BTAI Bioxcel Therapeutics, Inc. | Mehta Vimal92 | CEO, President &Secretary | Buy | 2,983 | $8.64 | $25,780.27 | +24.1% | |
| Aug 14, 2019 | ZTS Zoetis Inc. | Lewis Clinton A. Jr.46 | Executive Vice President | Sell | 6,123 | $123.51 | $756,257.58 | -7.4% | |
| Aug 14, 2019 | PCRX Pacira Biosciences, Inc. | Williams Kristen Marie76 | Chief Administrative Officer | Sell | 6,252 | $39.49 | $246,891.48 | -24.6% | |
| Aug 14, 2019 | AQST Aquestive Therapeutics, Inc. | Kendall Keith J | CEO And President | Buy | 8,000 | $3.87 | $30,987.00 | +0.2% | |
| Aug 13, 2019 | BTAI Bioxcel Therapeutics, Inc. | Mehta Vimal92 | CEO, President &Secretary | Buy | 1,000 | $8.75 | $8,750.00 | +20.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.